BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Qahtani AA, Al-Anazi MR, Al-Zoghaibi F, Abdo AA, Sanai FM, Khan MQ, Albenmousa A, Al-Ashgar HI, Al-Ahdal MN. The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients. Biomed Res Int 2014;2014:357062. [PMID: 25177689 DOI: 10.1155/2014/357062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sepehri Z, Kiani Z, Kohan F, Alavian SM, Ghavami S. Toll like receptor 4 and hepatocellular carcinoma; A systematic review. Life Sci 2017;179:80-7. [PMID: 28472619 DOI: 10.1016/j.lfs.2017.04.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
2 Xu Y, Xue W, Gao H, Cui J, Zhao L, You C. Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status. PeerJ 2022;10:e13335. [DOI: 10.7717/peerj.13335] [Reference Citation Analysis]
3 Pires-Neto Ode S, de Sá KS, Santana BB, Gomes ST, Amoras Eda S, Conde SR, Demachki S, Azevedo VN, Martins-Feitosa RN, Ishak Mde O, Ishak R, Vallinoto AC. Lack of Association between Polymorphisms of the TLR4 Gene and Infection with the Hepatitis B and C Viruses. Mediators Inflamm 2015;2015:150673. [PMID: 26347404 DOI: 10.1155/2015/150673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Khan A, Khan Z, Warnakulasuriya S. Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence? Annals of Oncology 2016;27:984-97. [DOI: 10.1093/annonc/mdw053] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chaiwiang N, Poyomtip T. The associations between Toll-like receptor 4 gene polymorphisms and hepatitis C virus infection: a systematic review and meta-analysis. Biosci Rep 2019;39:BSR20182470. [PMID: 30765614 DOI: 10.1042/BSR20182470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Grolmusz VK, Bozsik A, Papp J, Patócs A. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification. Front Immunol 2021;12:653489. [PMID: 33763088 DOI: 10.3389/fimmu.2021.653489] [Reference Citation Analysis]
7 Iqbal MS, Ashfaq UA, Khaliq S, Masoud MS, Qasim M, Haque A, Ghani MU, Jahan S. Toll-like receptor 4 polymorphism as pretreatment predictor of response to HCV genotype 3a interferon-based treatment. Future Virology 2017;12:739-46. [DOI: 10.2217/fvl-2017-0076] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Chen Yi Mei SL, Burchell J, Skinner N, Millen R, Matthews G, Hellard M, Dore GJ, Desmond PV, Sundararajan V, Thompson AJ, Visvanathan K, Sasadeusz J. Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection. J Infect Dis 2016;214:739-47. [PMID: 27284092 DOI: 10.1093/infdis/jiw235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kayesh MEH, Kohara M, Tsukiyama-Kohara K. Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview. Int J Mol Sci 2022;23:5475. [PMID: 35628287 DOI: 10.3390/ijms23105475] [Reference Citation Analysis]
10 Al-Anazi MR, Nazir N, Abdo AA, Sanai FM, Alkahtani S, Alarifi S, Alkahtane AA, Al-Yahya H, Ali D, Alessia MS, Al-Ahdal MN, Al-Qahtani AA. Genetic variations of NOD2 and MD2 genes in hepatitis B virus infection. Saudi J Biol Sci 2019;26:270-80. [PMID: 31485165 DOI: 10.1016/j.sjbs.2016.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Gao Y, Nepal N, Jin SZ. Toll-like receptors and hepatitis C virus infection. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00155-7. [PMID: 34419367 DOI: 10.1016/j.hbpd.2021.07.011] [Reference Citation Analysis]
12 Neamatallah M, El-Bendary M, Elalfy H, Besheer T, El-Maksoud MA, Elhammady D, Abed S, Elegezy M, Kandeel L, Eldeib D, Mousa N, Abd El-Hafeez M, El-Gilany AH, Esmat G. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients. Immunol Invest. 2020;49:462-476. [PMID: 31615295 DOI: 10.1080/08820139.2019.1673772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]